Adds to existing law to establish the Medical Advanced Healing Act.
MEDICAL ADVANCED HEALING ACT -- Adds to existing law to establish the Medical Advanced Healing Act.
STATEMENT OF PURPOSE
▶ Show statement of purpose▼ Hide statement of purpose
RS33592C1 / H0899 The Trump Administration’s 2024 National Defense Authorization Act (NDAA) allows states to begin studying rapid-acting therapies like neuroplastogens to treat conditions such as Post Traumatic Stress Disorder (PTSD) and Traumatic Brain Injury (TBI). This is because recent studies have shown neuroplastogens have the potential for more effective treatment of mental health conditions like anxiety and depression, trauma, and addiction. States like Indiana, Arizona, New Jersey, Mississippi, and Texas have begun the process of enacting pilot programs to study the effectiveness of these treatments. Particular focus is on the United States veteran population, which is experiencing an average of 22 suicides a day from returning soldiers whose serious mental health conditions are not being effectively treated by traditional medications. U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy stated the Trump administration’s goal is to make neuroplastogens widely available as soon as possible in the United States. The heads of the U.S. Department of Veterans Affairs (VA), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH) are also looking at the potential benefits of neuroplastogens. This legislation would create a revenue-neutral pilot program for Idaho to join in this effort.
FISCAL NOTE
▶ Show fiscal note▼ Hide fiscal note
This legislation causes no increase or decrease in revenue, or additional expenditure of funds at the state or local level of government; therefore, this legislation has no fiscal impact.
BILL TEXT
▶ Show full bill text▼ Hide full bill text
LEGISLATURE OF THE STATE OF IDAHO Sixty-eighth Legislature Second Regular Session - 2026 IN THE HOUSE OF REPRESENTATIVES HOUSE BILL NO. 899 BY HEALTH AND WELFARE COMMITTEE AN ACT1 RELATING TO THE MEDICAL ADVANCED HEALING ACT; AMENDING TITLE 39, IDAHO CODE,2 BY THE ADDITION OF A NEW CHAPTER 69, TITLE 39, IDAHO CODE, TO PROVIDE A3 SHORT TITLE, TO PROVIDE LEGISLATIVE FINDINGS, TO ESTABLISH A PILOT PRO-4 GRAM, TO DEFINE TERMS, TO PROVIDE FOR AUTHORIZED ACTIVITIES, SAFETY RE-5 QUIREMENTS, AND LIMITATIONS, TO ESTABLISH LICENSING AND RULEMAKING AU-6 THORITY, TO ESTABLISH A FUND, TO PROVIDE FOR DATA COLLECTION AND REPORT-7 ING, AND TO PROVIDE FOR LEGISLATIVE APPROVAL OF RULES; PROVIDING SEVER-8 ABILITY; AND DECLARING AN EMERGENCY.9
Be It Enacted by the Legislature of the State of Idaho:10
SECTION 1. That Title 39, Idaho Code, be, and the same is hereby amended11 by the addition thereto of a NEW CHAPTER, to be known and designated as Chap-12 ter 69, Title 39, Idaho Code, and to read as follows:13 CHAPTER 6914 MEDICAL ADVANCED HEALING ACT15 39-6901. SHORT TITLE. This chapter shall be known and may be cited as16 the "Medical Advanced Healing Act" or "MAHA."17 39-6902. LEGISLATIVE FINDINGS. The legislature finds and determines18 that:19 (1) Many Idahoans, especially veterans and first responders who have20 experienced job-related trauma, suffer from post-traumatic stress dis-21 order, depression, substance abuse disorder, traumatic brain injury, and22 other serious conditions that may not be adequately relieved with existing23 treatments;24 (2) Individuals who suffer from addiction to drugs or alcohol and for25 whom existing treatments are not providing relief may benefit from alterna-26 tive treatments;27 (3) Emerging research indicates that certain neuroplastogens may offer28 meaningful benefits to individuals who suffer from certain health con-29 ditions when delivered in a controlled clinical setting with appropriate30 screening, supervision, and follow-up care;31 (4) The national defense authorization act of 2024 allows states to32 partner with the secretary of war to study medicines such as psilocybin,33 MDMA, and ibogaine for treatment of serious behavioral health conditions;34 and35 (5) The department of war recently provided ten million dollars36 ($10,000,000) to study these emerging modalities.37
2 39-6903. ESTABLISHMENT OF PILOT PROGRAM. (1) The purpose of this chap-1 ter is to establish a carefully regulated pilot program housed in the depart-2 ment of health and welfare.3 (2) The pilot program shall be designed to provide initial access lim-4 ited to veterans, first responders, and those suffering from addiction.5 (3) The pilot program shall be designed to:6 (a) Protect public health and safety through strong screening, profes-7 sional standards, and diversion control;8 (b) Improve access to emerging therapeutic options for Idaho veterans;9 and10 (c) Generate Idaho-specific safety outcomes data to inform future leg-11 islative action.12 (4) The pilot program shall be administered in a revenue-neutral man-13 ner. The program shall be funded primarily through program fees and volun-14 tary grants or donations and not by ongoing general fund appropriations un-15 less authorized by future legislation.16 (5) Participation in the pilot program shall be voluntary. Nothing in17 this chapter shall be construed to require any person to participate in the18 pilot program.19 (6) The legislature shall retain full authority to modify, expand,20 limit, or discontinue the pilot program established pursuant to this chap-21 ter.22 39-6904. DEFINITIONS. As used in this chapter:23 (1) "Approved medicine" means a neuroplastogen or entheogenic sub-24 stance authorized for use in the program. Approved medicines shall be25 limited to:26 (a) Psilocybin;27 (b) 3,4-methylenedioxymethamphetamine (MDMA);28 (c) Ibogaine; and29 (d) Such additional medicines, if any, as may be subsequently autho-30 rized by the legislature.31 (2) "Department" means the Idaho department of health and welfare.32 (3) "Eligible participant" means a person who:33 (a) Is twenty-one (21) years of age or older;34 (b) Is a resident of Idaho;35 (c) Has a qualifying condition; and36 (d) Has been screened and approved for participation in the program37 pursuant to department rule.38 (4) "Program" means the medical advanced healing act (MAHA) pilot pro-39 gram established pursuant to this chapter.40 (5) "Qualifying condition" means post-traumatic stress disorder, ma-41 jor depressive disorder, substance use disorder, or another serious behav-42 ioral health condition identified by department rule based on clinical evi-43 dence and the purposes of this chapter.44 39-6905. AUTHORIZED ACTIVITIES -- SAFETY REQUIREMENTS -- LIMITA-45 TIONS. (1) To the extent consistent with the provisions of this chapter and46 federal law, it shall be lawful:47 (a) To obtain, possess, store, and administer approved medicines; and48
3 (b) For an eligible participant to possess and consume approved1 medicine during a supervised administration session pursuant to de-2 partment rule.3 (2) The department shall adopt rules to establish minimum safety stan-4 dards, including rules regarding:5 (a) Screening for medical and psychiatric contraindications;6 (b) Informed consent, including disclosure of material risks and al-7 ternatives;8 (c) Requirements for preparation and post-administration support ser-9 vices;10 (d) Minimum supervision requirements during administration sessions,11 including emergency procedures and referral pathways for higher-level12 care; and13 (e) Ethical standards and professional conduct requirements to prevent14 exploitation and abuse.15 (3) Approved medicines shall not be dispensed to a participant unless16 such participant is supervised. Unsupervised use shall be prohibited.17 (4) The department shall require secure storage, inventory controls,18 and recordkeeping sufficient to prevent diversion and to ensure account-19 ability.20 39-6906. LICENSING AND RULEMAKING. (1) The department shall promul-21 gate rules to implement and administer this chapter, including rules govern-22 ing:23 (a) Certification and training requirements;24 (b) Licensing standards, inspections, and security requirements;25 (c) Sourcing, testing, packaging, labeling, tracking, and disposal of26 approved medicines;27 (d) Participant eligibility, screening standards, and clinical proto-28 cols; and29 (e) Enforcement, including grounds for denial, suspension, and revoca-30 tion of licensure or certification.31 (2) In developing rules, the department shall consult with stakehold-32 ers. The department may coordinate with federal agencies.33 (3) The department may implement the program in phases and shall pri-34 oritize readiness and safety and adjust timelines by rule if necessary to35 safely operate the pilot program.36 39-6907. MAHA FUND. (1) There is hereby created in the state treasury37 the medical advanced healing act (MAHA) fund, which shall be administered by38 the department.39 (2) The department may establish reasonable fees by rule to support ad-40 ministration and oversight of the program, including licensing and renewal41 fees and a modest per-session program fee. All funds collected shall be de-42 posited into the MAHA fund for use by the program.43 (3) The department may accept payments, grants, gifts, or donations to44 support the program, including to subsidize participation by veterans, pro-45 vided that acceptance of such payments, grants, gifts, or donations does not46 create a conflict of interest or compromise program integrity. All funds47 collected shall be deposited into the MAHA fund for use by the MAHA program.48
4 (4) Moneys in the fund shall be used only for purposes of implementing,1 administering, and enforcing this chapter, subject to appropriation by the2 legislature.3 (5) The state treasurer shall invest the idle moneys of the MAHA fund,4 and the interest earned on such investments shall be retained by the MAHA5 fund.6 39-6908. DATA COLLECTION AND REPORTING. (1) The department shall col-7 lect de-identified program data sufficient to evaluate safety, outcomes,8 and program integrity.9 (2) Beginning one (1) year after the program commences services, and10 annually thereafter, the department shall report to the governor and germane11 committees of the legislature regarding:12 (a) The number of individuals served and general characteristics of13 participants;14 (b) The number and types of sessions conducted;15 (c) Aggregate safety outcomes;16 (d) Observed changes in clinical outcomes as available and appropri-17 ate; and18 (e) Program finances and fees.19 (3) The department's report may include recommendations for improving20 or expanding the program, including any proposed statutory changes.21 (4) The department's report to the legislature shall be provided pur-22 suant to the provisions of sections 67-466 and 67-705, Idaho Code.23 39-6909. LEGISLATIVE APPROVAL OF RULES. All rules established pur-24 suant to this chapter shall be subject to legislative approval.25
SECTION 2. SEVERABILITY. The provisions of this act are hereby declared26 to be severable and if any provision of this act or the application of such27 provision to any person or circumstance is declared invalid for any reason,28 such declaration shall not affect the validity of the remaining portions of29 this act.30
SECTION 3. An emergency existing therefor, which emergency is hereby31 declared to exist, this act shall be in full force and effect on and after its32 passage and approval.33
LATEST ACTION
Introduced, read first time, referred to JRA for Printing
BILL INFO
- Session
- 2026
- Chamber
- house
- Status date
- Mar 16, 2026
RELATED BILLS
More by Rob Beiswenger
